Jun 30, 2022 | Radiflow team
Synopsis:
Pharma companies discover, develop and manufacture both medication and medical equipment that range across Vaccines, Prescription and Over the Counter (OTC) medications. Many of these products are critical to either sustain life or cure illnesses.
Like all companies that run computer systems, they are not immune to cyberattack and in recent years, the industry is seeing an increase in debilitating attacks on both traditional IT systems and more recently Industrial Automation and Control Systems (Operational Technology [OT]), used typically across R&D, Manufacturing and Warehouses.
These attacks have the potential to halt both the discovery and production of medication and may lead to a lack of supply of patient critical mediation or devices.
